Positioning political selling, disclosed 2026-09-18
Options put/call open interest 0.54, read 2026-11-01
Ethical does not pass the values gate
Price38.55 USD
Fair value57.50
Ethical score10.0/100
RatingAVOID
Our investment reviews on this name
2026-10-23Read Markup36.01+7.1% to today ✓Distribution gives way to Markup after a 12% slide in 16 weeks
2026-07-02Read Distribution40.95-5.9% to today ✓First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Fidelity National Information Services holds its Markup at $38.55. Consolidating, no directional conviction, held for 7 days.
As held on the ledger · 2026-10-30
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 7 days
Price at the screen
$38.55
Valuation
5.92 trailing · 5.80 forward price to earnings
Values screen
FAIL· score 10.0
Beta
0.83
The Workings
Five Screens, Shown in Full
Does not pass. Business activity screen
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Business activity: Financials sector
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Fidelity National Information Services does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-31. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when FIS's ethical verdict changes
Today FIS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads AVOID: it trades at roughly a 49% discount to our $57.50 fair value, moderate competitive moat, 29.10% revenue growth.
Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. A 49.2% margin of safety to the base estimate.
Where our models see it going: fair-value estimate $57.50, with a range of $57.50 to $77.10, dated to the 2026-10-30 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Banking tech fails ethics before value
Every time a bank clears a payment or processes a loan the software underneath often traces back to FIS. The numbers look tempting with 30 percent revenue growth, a 23 percent profit margin and a forward multiple of just 6.1 times earnings. Yet the business activity screen blocks any further look, so we pass.
The moderate moat and 17 percent return on equity cannot offset the ethical failure. Analysts may cluster around a 55 dollar target while our own fair value sits higher, but those figures never reach the table once the screen is triggered.
Currency moves and contract concentration add normal sector risk, yet the ethical call remains the binding constraint. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
FIS trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Markup$38.55+0.0%Entry 13
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (21 analysts) rates it buy, with a mean price target of $59. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Markup$38.55+2.7%Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (21 analysts) rates it buy, with a mean price target of $59. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Markup$37.53+0.0%Entry 11
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (21 analysts) rates it buy, with a mean price target of $59. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Markup$37.53+4.2%Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (21 analysts) rates it buy, with a mean price target of $59. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markup$36.01+0.0%Entry 9
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (21 analysts) rates it buy, with a mean price target of $59. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markup · changed$36.01+2.3%Entry 8
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (21 analysts) rates it buy, with a mean price target of $59.
2026-10-16Distribution$35.20+2.6%Entry 7
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (21 analysts) rates it buy, with a mean price target of $59.
2026-10-02Distribution$34.31-17.0%Entry 6
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 17.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (21 analysts) rates it buy, with a mean price target of $59.
2026-08-29Distribution$41.34-1.4%Entry 5
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (21 analysts) rates it buy, with a mean price target of $59.
2026-07-28Distribution$41.91+2.3%Entry 4
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (21 analysts) rates it buy, with a mean price target of $59.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.